Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms

Table 3

Descriptive statistics for questionnaire data.

	−4 w			Day 0			Week 12
	M	SD	95% CI	M	SD	95% CI	M	SD	95% CI
VSI	43.92	14.14	38.25, 53.91	41.06	17.21	31.35, 47.32	21.2	14.74	14.42, 26.41
GSRS	40.23	12.98	34.50, 49.50	37.83	14.67	31.04, 50.30	29.8	13.82	22.52, 41.32
HADS-T	14.00	5.66	10.41, 17.59	14.22	5.75	11.34, 18.16	11.3	6.39	7.96, 15.54
HADS-D	3.83	2.79	2.06, 5.61	4.5	2.81	2.91, 6.59	2.8	2.55	1.33, 4.67
HADS-A	10.17	3.30	8.07, 12.26	9.72	3.68	7.85, 12.15	8.56	4.19	6.36, 11.14

Note. Means (M), medians (Mdn), standard deviations (SD), and 95% confidence intervals (CI) for dependent variables of visceral sensitivity index (VSI), Gastrointestinal Symptoms Rating Scale (GSRS), and hospital anxiety and depression symptom scale (total, anxiety, and depression) in subjects with IBS collected four weeks before (−4 weeks), just before (day 0), and after cognitive behavioral therapy (CBT) (12 weeks). < 0.05, < 0.01.